|Articles|August 1, 2015
- BioPharm International-08-01-2015
- Volume 28
- Issue 8
BioPharm International, August 2015 Issue (PDF)
Click the title above to open the BioPharm International August 2015 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 10 years ago
Drug Delivery Systems for Biopharmaceuticalsover 10 years ago
Selecting a Comprehensive Bioburden Reduction Planover 10 years ago
Mastering Cell Bank Productionover 10 years ago
Campaign Against Fake Drugs Gains Momentumover 10 years ago
Outsourcing Becoming More Cost Competitiveover 10 years ago
Finding a Cure for Early Pipeline Failuresover 10 years ago
Cleaning of Dedicated Equipment: Why Validation is Neededover 10 years ago
Fluid Handling in Biopharma FacilitiesNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
New Draft Guidance Highlights FDA Push Toward Human-Relevant Safety Models
2
Implementing Automation and Flexible Design for Allogeneic Manufacturing
3
Regulatory Uncertainty Surfaces as FDA Blames COVID Vaccines for 10 Child Deaths
4
Neurimmune and AstraZeneca Expand Efforts to Accelerate Fibril-Depleting Therapies
5
